risedronic acid has been researched along with Centriacinar Emphysema in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We analyzed patients with chronic obstructive pulmonary disease whose bone mineral density were measured at least three times over three years (n = 111)." | 1.51 | Predictive and modifying factors of bone mineral density decline in patients with COPD. ( Asano, K; Betsuyaku, T; Chubachi, S; Fukunaga, K; Irie, H; Kameyama, N; Nakamura, H; Sakurai, K; Sasaki, M; Sayama, K; Tsutsumi, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkady, OA | 1 |
| Saleh, LM | 1 |
| Tadros, MI | 1 |
| El-Laithy, HM | 1 |
| Kameyama, N | 1 |
| Chubachi, S | 1 |
| Sasaki, M | 1 |
| Tsutsumi, A | 1 |
| Irie, H | 1 |
| Sakurai, K | 1 |
| Sayama, K | 1 |
| Nakamura, H | 1 |
| Asano, K | 1 |
| Betsuyaku, T | 1 |
| Fukunaga, K | 1 |
2 other studies available for risedronic acid and Centriacinar Emphysema
| Article | Year |
|---|---|
Nebulization of Risedronate Sodium Microspheres for Potential Attenuation of Pulmonary Emphysema: a Promising New Insight of Alveolar Macrophage Apoptosis.
Topics: Animals; Apoptosis; Lung; Macrophages, Alveolar; Microspheres; Nebulizers and Vaporizers; Pulmonary | 2021 |
Predictive and modifying factors of bone mineral density decline in patients with COPD.
Topics: Aged; Aged, 80 and over; Bone Density; Bone Density Conservation Agents; Comorbidity; Female; Humans | 2019 |